Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade

Maria Lucia Cascavilla, Giuseppe Querques, Lea Querques, Marco Codenotti, Francesco Bandello

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

To report on intravitreal Ranibizumab for intervening myopic choroidal neovascularization (CNV) in a case of retinal detachment successfully repaired with pars plana vitrectomy and silicone oil tamponade. Methods: Intravitreal ranibizumab was performed in a 67-year-old woman with CNV complicating pathologic myopia. The patient had previously undergone vitrectomy and silicone oil tamponade for retinal detachment. Results: At 2 months from intravitreal ranibizumab, best-corrected visual acuity (BCVA) improved from count fingers to 20/100, and intraocular pressure (IOP) was 16 mm Hg. Fluorescein angiography (FA) and spectral-domain optical coherence tomography (SD-OCT) showed resolution of late leakage and subretinal/intraretinal fluid, respectively. Conclusions: Administration of intravitreal anti-VEGF in patients with silicone oil as intraocular tamponade may represent an intriguing treatment option. Our results suggest that intravitreal injections of Ranibizumab may lead to a rapid improvement in both functional (BCVA) and morphologic (FA and SD-OCT) parameters of CNV activity, without significant rise in IOP, in eyes with silicone oil as intraocular tamponade.

Original languageEnglish
Pages (from-to)913-916
Number of pages4
JournalEuropean Journal of Ophthalmology
Volume23
Issue number6
DOIs
Publication statusPublished - Jun 23 2013

Fingerprint

Silicone Oils
Choroidal Neovascularization
Temazepam
Vitrectomy
Fluorescein Angiography
Optical Coherence Tomography
Retinal Detachment
Intraocular Pressure
Visual Acuity
Subretinal Fluid
Intravitreal Injections
Myopia
Vascular Endothelial Growth Factor A
Fingers
Ranibizumab

Keywords

  • Anti-vascular endothelial growth factor
  • Choroidal neovascularization
  • Pars plana vitrectomy
  • Pathologic myopia
  • PDMS
  • Ranibizumab
  • Silicone oil

ASJC Scopus subject areas

  • Ophthalmology
  • Medicine(all)

Cite this

Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade. / Cascavilla, Maria Lucia; Querques, Giuseppe; Querques, Lea; Codenotti, Marco; Bandello, Francesco.

In: European Journal of Ophthalmology, Vol. 23, No. 6, 23.06.2013, p. 913-916.

Research output: Contribution to journalArticle

Cascavilla, Maria Lucia ; Querques, Giuseppe ; Querques, Lea ; Codenotti, Marco ; Bandello, Francesco. / Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade. In: European Journal of Ophthalmology. 2013 ; Vol. 23, No. 6. pp. 913-916.
@article{d5980fdf44b343e882c55b55a347e80e,
title = "Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade",
abstract = "To report on intravitreal Ranibizumab for intervening myopic choroidal neovascularization (CNV) in a case of retinal detachment successfully repaired with pars plana vitrectomy and silicone oil tamponade. Methods: Intravitreal ranibizumab was performed in a 67-year-old woman with CNV complicating pathologic myopia. The patient had previously undergone vitrectomy and silicone oil tamponade for retinal detachment. Results: At 2 months from intravitreal ranibizumab, best-corrected visual acuity (BCVA) improved from count fingers to 20/100, and intraocular pressure (IOP) was 16 mm Hg. Fluorescein angiography (FA) and spectral-domain optical coherence tomography (SD-OCT) showed resolution of late leakage and subretinal/intraretinal fluid, respectively. Conclusions: Administration of intravitreal anti-VEGF in patients with silicone oil as intraocular tamponade may represent an intriguing treatment option. Our results suggest that intravitreal injections of Ranibizumab may lead to a rapid improvement in both functional (BCVA) and morphologic (FA and SD-OCT) parameters of CNV activity, without significant rise in IOP, in eyes with silicone oil as intraocular tamponade.",
keywords = "Anti-vascular endothelial growth factor, Choroidal neovascularization, Pars plana vitrectomy, Pathologic myopia, PDMS, Ranibizumab, Silicone oil",
author = "Cascavilla, {Maria Lucia} and Giuseppe Querques and Lea Querques and Marco Codenotti and Francesco Bandello",
year = "2013",
month = "6",
day = "23",
doi = "10.5301/ejo.5000337",
language = "English",
volume = "23",
pages = "913--916",
journal = "European Journal of Ophthalmology",
issn = "1120-6721",
publisher = "Wichtig Publishing",
number = "6",

}

TY - JOUR

T1 - Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade

AU - Cascavilla, Maria Lucia

AU - Querques, Giuseppe

AU - Querques, Lea

AU - Codenotti, Marco

AU - Bandello, Francesco

PY - 2013/6/23

Y1 - 2013/6/23

N2 - To report on intravitreal Ranibizumab for intervening myopic choroidal neovascularization (CNV) in a case of retinal detachment successfully repaired with pars plana vitrectomy and silicone oil tamponade. Methods: Intravitreal ranibizumab was performed in a 67-year-old woman with CNV complicating pathologic myopia. The patient had previously undergone vitrectomy and silicone oil tamponade for retinal detachment. Results: At 2 months from intravitreal ranibizumab, best-corrected visual acuity (BCVA) improved from count fingers to 20/100, and intraocular pressure (IOP) was 16 mm Hg. Fluorescein angiography (FA) and spectral-domain optical coherence tomography (SD-OCT) showed resolution of late leakage and subretinal/intraretinal fluid, respectively. Conclusions: Administration of intravitreal anti-VEGF in patients with silicone oil as intraocular tamponade may represent an intriguing treatment option. Our results suggest that intravitreal injections of Ranibizumab may lead to a rapid improvement in both functional (BCVA) and morphologic (FA and SD-OCT) parameters of CNV activity, without significant rise in IOP, in eyes with silicone oil as intraocular tamponade.

AB - To report on intravitreal Ranibizumab for intervening myopic choroidal neovascularization (CNV) in a case of retinal detachment successfully repaired with pars plana vitrectomy and silicone oil tamponade. Methods: Intravitreal ranibizumab was performed in a 67-year-old woman with CNV complicating pathologic myopia. The patient had previously undergone vitrectomy and silicone oil tamponade for retinal detachment. Results: At 2 months from intravitreal ranibizumab, best-corrected visual acuity (BCVA) improved from count fingers to 20/100, and intraocular pressure (IOP) was 16 mm Hg. Fluorescein angiography (FA) and spectral-domain optical coherence tomography (SD-OCT) showed resolution of late leakage and subretinal/intraretinal fluid, respectively. Conclusions: Administration of intravitreal anti-VEGF in patients with silicone oil as intraocular tamponade may represent an intriguing treatment option. Our results suggest that intravitreal injections of Ranibizumab may lead to a rapid improvement in both functional (BCVA) and morphologic (FA and SD-OCT) parameters of CNV activity, without significant rise in IOP, in eyes with silicone oil as intraocular tamponade.

KW - Anti-vascular endothelial growth factor

KW - Choroidal neovascularization

KW - Pars plana vitrectomy

KW - Pathologic myopia

KW - PDMS

KW - Ranibizumab

KW - Silicone oil

UR - http://www.scopus.com/inward/record.url?scp=84885899234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885899234&partnerID=8YFLogxK

U2 - 10.5301/ejo.5000337

DO - 10.5301/ejo.5000337

M3 - Article

VL - 23

SP - 913

EP - 916

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

SN - 1120-6721

IS - 6

ER -